NCT01481402

Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Left Ventricular Ejection Fraction (LVEF)

Liothyronine and Heart Failure. The Long Term Effect of Liothyronine on Heart Function, Body Composition and Metabolic Status

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 21 (actual)
• Sponsor: Jens Faber · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Purpose: The purpose of the study is to examine if treatment with liothyronine increases left ventricular ejection fraction (LVEF) in patients with stable, chronic heart failure.

Detailed description

The patients are examined 3 times. At baseline, after 3 months and after 6 months.After the examination is performed, they begin the study medication while admitted at Dept. of Cardiology, Herlev Hospital, for cardiac monitoring.

Conditions

• Heart Failure
• Low T3 Syndrome

Interventions

Type	Name	Description
DRUG	Liothyronine	Liothyronine 40 microgram per day
DRUG	Liothyronine	3 months of placebo followed by 3 months of Liothyronine 40 microgram per day (oral)

Timeline

• Start date: 2011-07-01
• Primary completion: 2014-02-01
• Completion: 2014-02-01
• First posted: 2011-11-29
• Last updated: 2019-07-16

Locations

1 site across 1 country: Denmark